- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/21 - Peptides ayant plus de 20 amino-acides; Gastrines; Somatostatines; Mélanotropines; Leurs dérivés provenant de bactéries provenant de Pseudomonadaceae (F)
Détention brevets de la classe C07K 14/21
Brevets de cette classe: 543
Historique des publications depuis 10 ans
|
53
|
43
|
61
|
52
|
51
|
53
|
33
|
32
|
28
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Pioneer Hi-Bred International, Inc. | 6372 |
46 |
| Glaxosmithkline Biologicals S.A. | 1698 |
39 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2832 |
24 |
| Aridis Pharmaceuticals Inc. | 30 |
11 |
| University of Maryland, Baltimore | 1002 |
9 |
| The Board of Trustees of the University of Illinois | 2666 |
7 |
| Viventia Bio Inc. | 24 |
7 |
| Wake Forest University Health Sciences | 716 |
7 |
| President and Fellows of Harvard College | 5911 |
6 |
| Arch Biophysics, Inc. | 5 |
5 |
| Arne Forsgren AB | 7 |
5 |
| Plant Health Care, Inc. | 54 |
5 |
| Spogen Biotech Inc. | 129 |
5 |
| Applied Molecular Transport Inc. | 19 |
5 |
| Evonik Operations GmbH | 4022 |
5 |
| Corteva Agriscience LLC | 2680 |
5 |
| Evaxion Biotech A/S | 44 |
5 |
| BASF SE | 20403 |
4 |
| E. I. du Pont de Nemours and Company | 4251 |
4 |
| Janssen Pharmaceuticals, Inc. | 411 |
4 |
| Autres propriétaires | 335 |